Xtant Medical to Present at the Source Capital 2016 Disruptive Growth & Healthcare Conference

Xtant Medical to Present at the Source Capital 2016 Disruptive

Growth & Healthcare Conference

BELGRADE, Mont., Feb. 3, 2016 (GLOBE NEWSWIRE) - Xtant Medical

Holdings, Inc. (NYSE MKT: XTNT), formerly Bacterin International Holdings, Inc., a leader in the development of class-leading regenerative

medicine products and medical devices, today announced that its Chief Executive Officer, Dan Goldberger and Chief Financial Officer,

John Gandolfo will present at the inaugural Source Capital 2016 Disruptive Growth & Healthcare Conference, to be held February

10-11, 2016 at the Convene Conference Center in New York City, NY. Xtant Medical's presentation will take place Wednesday, February

10, 2016 at 10:15 AM Eastern Time.

A live broadcast of the conference presentation will be available.

To access the broadcast, go to the "Investor Info" section of the Company's website at www.xtantmedical.com. A replay

of the conference presentation will also be available.

About Xtant Medical Holdings

Xtant Medical Holdings, Inc. (NYSE MKT: XTNT) develops, manufactures

and markets class-leading regenerative medicine products and medical devices for domestic and international markets. Xtant products

serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing,

implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and

biologics to promote healing following cranial, foot and ankle surgeries. With core competencies in both biologic and non-biologic

surgical technologies, Xtant can leverage its resources to successfully compete in global neurological and orthopedic surgery markets.

For further information, please visit www.xtantmedical.com.

Important Cautions Regarding Forward-looking Statements

This press release contains certain disclosures that may be deemed

forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to significant

risks and uncertainties. Forward-looking statements include statements that are predictive in nature, that depend upon or refer

to future events or conditions, or that include words such as "continue," "efforts," "expects," "anticipates,"

"intends," "plans," "believes," "estimates," "projects," "forecasts,"

"strategy," "will," "goal," "target," "prospects," "potential," "optimistic,"

"confident," "likely," "probable" or similar expressions or the negative thereof. Statements of historical

fact also may be deemed to be forward-looking statements. We caution that these statements by their nature involve risks and uncertainties,

and actual results may differ materially depending on a variety of important factors, including, among others: the Company's ability

to successfully integrate the acquisition of X-spine; the ability of the Company's sales force to achieve expected results, the

Company's ability to meet its existing and anticipated contractual obligations, including financial covenant and other obligations

contained in the Company's secured lending facility; the Company's ability to manage cash flow; the Company's ability to develop,

market, sell and distribute desirable applications, products and services and to protect its intellectual property; the ability

of the Company's customers to pay and the timeliness of such payments; the Company's ability to obtain financing as and when needed;

changes in consumer demands and preferences; the Company's ability to attract and retain management and employees with appropriate

skills and expertise; the impact of changes in market, legal and regulatory conditions and in the applicable business environment,

including actions of competitors; and other factors. Additional risk factors are listed in the Company's Annual Report on Form

10-K and Quarterly Reports on Form 10-Q under the heading "Risk Factors." The Company undertakes no obligation to release

publicly any revisions to any forward-looking statements to reflect events or circumstances after the date hereof or to reflect

the occurrence of unanticipated events, except as required by law.